Novartis India Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 801.7 million compared to INR 989.6 million a year ago. Revenue was INR 885.3 million compared to INR 1,050 million a year ago. Net income was INR 76.1 million compared to INR 63.5 million a year ago. Basic earnings per share from continuing operations was INR 3.08 compared to INR 2.57 a year ago.
For the nine months, sales was INR 3,026.1 million compared to INR 3,015.5 million a year ago. Revenue was INR 3,443.5 million compared to INR 3,204.3 million a year ago. Net income was INR 783.4 million compared to INR 196.5 million a year ago. Basic earnings per share from continuing operations was INR 31.74 compared to INR 7.96 a year ago.